Story Navigation
-
People and CultureInnovationWorking at NovartisCareersFlexibility at Novartis: Ana Graf
Graf explains how flexible working has contributed to her success.
People and Culture -
DiscoveryInnovationNovartis Institutes for BioMedical ResearchWorking at NovartisOn being and becoming a data science company
A conversation with Novartis Chief Digital Officer Bertrand Bodson
Discovery -
From Our LabsNeuroscienceNovartis Institutes for BioMedical ResearchWomen in ScienceWorking at NovartisReimagine MedicineWomen in Science: Marjorie Eiref
Marjorie Eiref, Head of Operations for Neuroscience Research at Novartis, describes how her family medical history has impacted her career.
From Our Labs -
DiscoveryEmerging TechnologyFuture of HealthcareReimagine MedicineDigital health ecosystem gets a boost with the Novartis BiomeDiscovery
-
DiscoveryCancerCell and Gene TherapyNovartis Institutes for BioMedical ResearchClinical ResearchClinical TrialsResearchers boost understanding of T-cell therapy in blood cancer
Novartis investigators find genetic explanations for why some young patients relapse.
Discovery -
People and CultureSocial CommitmentWorking at NovartisCareersNudging bias out of the organization
Our Global Head of Talent Acquisition & Staffing talks about ongoing recruitment efforts to create a more diverse and inclusive organization.
People and Culture -
CancerDisease AwarenessOncologyPatient EducationPatient VoicesThe ABCDEs of melanoma prevention and detection
Melanoma survivor T.J. Sharpe discusses skin cancer prevention and detection, and shares tips on how to keep you and your loved ones safe in the sun.
-
DiscoveryDiseasesDrug DiscoveryNovartis Institutes for BioMedical ResearchDrug DevelopmentTeaming up with academia to discover medicines
The Novartis Faculty of Scholars initiative connects academic researchers with deep knowledge and big ideas to scientists in its drug discovery labs.
Discovery -
From Our LabsNeurodegenerative DiseaseNeuroscienceClinical TrialsAlzheimer’s diseaseGene TestingNeuroscientists target Alzheimer’s “silent stage”
Research exploring the first visible changes in the brain is helping scientists evaluate new potential treatments for Alzheimer’s.
From Our Labs -
DiscoveryDrug DiscoveryEmerging TechnologyInnovationNovartis Institutes for BioMedical ResearchDrug DevelopmentNew drug manufacturing tools change pharma chemistry
The modernization and miniaturization of pharmaceutical production could expand the range of ingredients medicinal chemists use to make new drugs.
Discovery -
DiscoveryChronic IllnessDigitalDiseasesNovartis Institutes for BioMedical ResearchNew Scientific DiscoveriesScientific ResearchEmbracing big data to understand complex diseases
Researchers discover that networks of proteins circulating in the blood influence the development and progression of chronic diseases.
Discovery -
DiscoveryDiseasesDrug DiscoveryNovartis Institutes for BioMedical ResearchScientific ResearchGenetic DiseaseDiscovery gives cystic fibrosis researchers new direction
Novartis-Harvard team identifies a new type of cell that is key to the disease.
Discovery
Pagination
- ‹ Previous page
- 1
- …
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- …
- 32
- › Next page